| Name | JNJ-64264681 |
|---|
| Description | JNJ-64264681 is a potent, orally active, selective and irreversible covalent BTK inhibitor. JNJ-64264681 exhibits good pharmacokinetic characteristics and can be used for cancer and autoimmune diseases research[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C27H30N6O3S |
|---|---|
| Molecular Weight | 518.63 |